11:21 AM EDT, 05/30/2024 (MT Newswires) -- Burning Rock Biotech ( BNR ) said Thursday it will work with Bayer to develop next-generation sequencing-based companion diagnostic assays to increase patient access to precision cancer medicines in China.

Financial terms weren't disclosed.

Burning Rock shares fell 4.8% in recent trading Thursday. The company on Wednesday reported Q1 revenue and non-GAAP gross profit declined from a year earlier.

Price: 7.40, Change: -0.37, Percent Change: -4.76